跳至主要内容
临床试验/CTRI/2026/04/107643
CTRI/2026/04/107643尚未招募不适用

Efficacy and safety of hypertonic saline with furosemide in nephrotic syndrome edema: an open-label non-inferiority randomized controlled trial

Suchitra R1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年4月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1

研究概览

简要总结

The participants will be enrolled only when we get the CTRI registration number. Both the study drugs Hypertonic saline and albumin are routinely used in pediatric ward, hence no trial related injury is expected.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Outcome Assessor Blinded

入排标准

年龄范围
1.00 Year(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • 1 to 14 year old with nephrotic syndrome with moderate to severe edema
  • Sodium avidity evidenced by FENa less than 0.5% or urine sodium less than equal to 20mmol/l
  • eGFR more than 60ml/min/1.73m2
  • Serum albumin less than 2g/dl.

排除标准

  • Secondary forms of nephrotic syndrome
  • Serum sodium more than 145meq/l
  • Clinical hypovolemia, pulmonary edema and congestive cardiac failure
  • Have used diuretics or albumin in the last 24 hours 5.Hypersensitivity to albumin or hypertonic saline 6.Previously included in study.

研究者

发起方
Suchitra R
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Suchitra R

Aiims Mangalagiri

研究点 (1)

Loading locations...

相似试验